[email protected]
CAS 93957-55-2 Fluvastatin Sodium Salt molecular structure lightbox
CAS RN: 93957-55-2

Fluvastatin Sodium Salt

Product Availability

Choose a grade to view its available package options.

12 package records12 with current stock3 grade groups
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250712 1g In stock Inquiry
Batchno.20250218 250mg In stock Inquiry
Batchno.20250422 50mg In stock Inquiry
Batchno.20250416 5g In stock Inquiry
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20260421 1ml In stock Inquiry
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20260108 100mg In stock Shanghai, Tianjin Inquiry
Batchno.20250503 1g In stock Shanghai Inquiry
Batchno.20260505 1mg In stock Shanghai, Tianjin, Wuhan Inquiry
Batchno.20250308 250mg In stock Shanghai, Wuhan Inquiry
Batchno.20250612 50mg In stock Shanghai, Wuhan Inquiry
Batchno.20260626 50mg / 250mg / 1g / 5g Confirm by inquiry Shanghai, Shandong Inquiry
Batchno.20250301 5g In stock Shanghai Inquiry
  • Product code: ICTF0820
  • Purity/Analytical Methods: >98.0%(HPLC)(N)
GET A QUOTE

93957-55-2 / sodium (E)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoate

Standard CAS: 93957-55-2 Multi CAS: Yes
Basic Information Computed Properties

Basic Information

CAS
93957-55-2
Multi CAS
Yes
Molecular Formula
C24H25FNNAO4
Molecular Weight
433.400000
Exact Mass
433.166531
InChI
InChI=1S/C24H26FNO4.Na/c1-15(2)26-21-6-4-3-5-20(21)24(16-7-9-17(25)10-8-16)22(26)12-11-18(27)13-19(28)14-23(29)30;/h3-12,15,18-19,27-28H,13-14H2,1-2H3,(H,29,30);/q;+1/p-1/b12-11+;
InChIKey
ZGGHKIMDNBDHJB-CALJPSDSSA-M

Computed Properties

Structural Parameters

Heavy atom count
31
Aromatic heavy atom count
15
Fraction Csp3
0.29
Rotatable bonds
8
H-bond acceptors
5
H-bond donors
2
Molar refractivity
113.01
TPSA
85.52

LogP / Solubility

WLOGP
0.3
MLOGP
0.29
XLogP3
0.3
Consensus LogP
0.3
Log S (ESOL)
-2.54
Class (ESOL)
Moderately soluble
Log S (Ali)
-3.33
Class (Ali)
Poorly soluble
Log S (SILICOS-IT)
-3.68
Class (SILICOS-IT)
Poorly soluble

ADME

GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-5.15

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
3.5

Customers Also Viewed

Get In Touch

Contact Us